Although the analysis of Kaplan–Meier survival rate and log-rank test revealed a correlation between USP36 levels and overall survival (OS) in liver hepatocellular carcinoma (LIHC) (Figure 5), there are lots of studies verifying that USP36 is implicated in the progression and drug resistance of many other cancers. The gene discussed is USP36; the disease is cancer.